LaboratorioSaludTexto original en inglés
In lab, lung tumor bacteria and a B2 metabolite activate MAIT cells
The result is limited to cell cultures; mouse tests of tumor injections are being pursued.
Redactado por IA1 fuente1 min
Loading…
Diagnósticos, prótesis, vacunas, genómica: la medicina que gana años de vida.
The result is limited to cell cultures; mouse tests of tumor injections are being pursued.
NTU and UIUC scanned people at 7T while they weighed stakes, acted, and assessed outcomes.
Julie Kim’s team used patient-derived iPSCs to make stromal cells carrying endometriosis-linked biology.
The ASPIRE phase 1/2 trial tested four targeted drugs in 29 previously untreated patients.
Washington University researchers developed NGSE-Corr to compare imaging tools when the true measurement is unknown.
Risca's team tracked liposarcoma and ER-positive breast cancer cells for nearly a month.
A six-month UIC trial assigned 32 adults to time-restricted eating, calorie reduction or no dietary change.
Sanford Burnham Prebys researchers identified Firefox and Honeybadger as opposing regulators of MYC-driven tumors.
Researchers at Birmingham and UCL compared 82 ultrasound detectors used in photoacoustic imaging.
A three-week program helped patients retain everyday abilities better than usual unstructured rehabilitation.
Yonsei researchers analyzed oral microbes from 507 volunteers, including people with gastric and colorectal cancer.
ASU researchers studied 8,687 blood samples from 4,089 people across healthy and immunosuppressed groups.
Monash University developed living kidney organoids that reproduce key features of human acute kidney injury.
The trial covered 20 Colombian urban areas, each with around 1,600 to 2,000 households.
The combination outperformed either treatment alone in a preclinical female-rodent model.
It targets BCL6, which normally silences genes that can stop growth or trigger programmed cell death.
An Australian team screened 63 existing medicines in patient-derived brain cells.
The University of Surrey study identified three distinct five-year health trajectories among 12,701 UK heart-attack survivors.